Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Paradigm BioDevices is a medical technology company specializing in the development and distribution of innovative surgical instruments and implants for spine and orthopedic procedures. The company is best known for its QuickDraw Bone Marrow Aspiration Needle, which is designed to efficiently harvest high-quality bone marrow aspirate for use in regenerative medicine and bone grafting. Founded in 1998 and headquartered in Massachusetts, Paradigm focused on providing minimally invasive solutions to improve clinical outcomes in spinal fusion. In 2013, the company was acquired by RTI Biologics (now RTI Surgical) to bolster their portfolio of biologic and hardware solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Paradigm BioDevices.